Evercore ISI Group Downgrades Cerence to In-Line, Announces $55 Price Target
Evercore ISI Group analyst Chris McNally downgrades Cerence (NASDAQ:CRNC) from Outperform to In-Line and announces $55 price target.
What 13 Analyst Ratings Have To Say About Cerence
Within the last quarter, Cerence (NASDAQ:CRNC) has observed the following analyst ratings:
Looking Into Cerence’s Return On Capital Employed
According to Benzinga Pro, during Q1, Cerence (NASDAQ:CRNC) earned $19.04 million, a 138.32% increase from the preceding quarter. Cerence also posted a total of $94.43 million in sales, a 41.02% increase since Q4.
10 Biggest Price Target Changes For Tuesday
Keybanc raised Take-Two Interactive Software, Inc. (NASDAQ: TTWO) price target from $185 to $190. Take-Two Interactive shares fell 2.8% to $170.21 in pre-market trading.
Wedbush Downgrades Cerence to Neutral, Lowers Price Target to $45
Wedbush analyst Daniel Ives downgrades Cerence (NASDAQ:CRNC) from Outperform to Neutral and lowers the price target from $115 to $45.
47 Biggest Movers From Yesterday
Gainers
Nuvectis Pharma, Inc. (NASDAQ: NVCT) shares surged 144.6% to close at $7.95 on Monday. The company, on Friday, priced its IPO at $5 per share.
RBC Capital Downgrades Cerence to Underperform, Announces $37 Price Target
RBC Capital analyst Joseph Spak downgrades Cerence (NASDAQ:CRNC) from Sector Perform to Underperform and announces $37 price target.
Raymond James Maintains Outperform on Cerence, Lowers Price Target to $76
Raymond James analyst Brian Gesuale maintains Cerence (NASDAQ:CRNC) with a Outperform and lowers the price target from $100 to $76.
Mid-Afternoon Market Update: Dow Surges Over 150 Points; Tyson Foods Beats Views
US stocks traded higher later during the session, with the Dow Jones index adding more than 150 points on Monday.